EMHTF - Emerald Health Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
2.9600
+0.3900 (+15.18%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close2.5700
Open0.0000
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Volume100
Avg. Volume470,672
Market Cap416.747M
Beta (3Y Monthly)2.55
PE Ratio (TTM)N/A
EPS (TTM)-0.13
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • CNW Group47 minutes ago

    Hemp-CBD Infused Products Craze Picking Up Momentum for Canadian and U.S. Stocks

    PALM BEACH, Florida , Feb. 21, 2019 /CNW/ -- U.S. and Canadian cannabis companies, witnessing the CBD-rush, have started developing their own strategies to tap the plant's potential. Just recently, Canopy ...

  • ACCESSWIRE2 hours ago

    How the Government Helped Create a $3 to $300 Stock Windfall, and Could Do it Again

    The Human Genome Project changed the scientific landscape completely, spurring major public and private investment into understanding human DNA. A newer government-backed effort called the BRAIN Initiative seeks to map the human brain, similar in scope to the Human Genome project. This initiative will fund major progress in neurology in the same way, and it coincides with a recent surge in investor interest in new technology targeting the nervous system.

  • ACCESSWIRE20 hours ago

    Watch These Marijuana Stocks Push Their Limits

    Generations earlier, many people believed cannabis to be a harmful substance and demanded that the federal government keep it out of the hands of consumers, but as we've come to understand, cannabis has a myriad of health benefits and is nothing to be afraid of. Over the past few years, cannabis companies have continued to release new products with medical cannabis for the purpose of improving the quality of treatment options available for consumers in the healthcare space. ), Aphria Inc (APHA), Emerald Health Therapeutics Inc (EMHTF) (EMH.V) and Tilray Inc (TLRY) are four companies that could test February highs.

  • GlobeNewswireyesterday

    Emerald Health Therapeutics Launches 88,000 Square Foot State-of-the-Art, Fully-Integrated Indoor Facility and Verdélite Brand in Québec

    OTCQX: EMHTF) today announced the launch of Verdélite Sciences Inc. ("Verdélite"), a wholly-owned, Québec-based production subsidiary licensed by Health Canada. Formerly known as Agro-Biotech, Verdélite currently produces high-grade dried cannabis for medical and adult-use purposes. Emerald is nearing completion of its over $100 million investment to secure and expand its multi-purpose facility to 88,000 square feet and enable the complete cycle of indoor cultivation, product development and automated packaging of cannabis products.

  • ACCESSWIRE2 days ago

    Cannabis Consumable Plays on the Rise

    HENDERSON, NV / ACCESSWIRE / February 19, 2019 / Below are several cannabis companies who produce consumer products that look ripe for a bull run. One we think has explosive growth potential is Real Brands, ...

  • CNW Group6 days ago

    Specialized Security Firms Enter the Cannabis Market Space

    NEW YORK, Feb. 15, 2019 /CNW/ -- The demand for security in the cannabis sector has increased substantially as more businesses are becoming operational and as a result, companies involved in fields such as cultivation, retail, and distribution are seeking security services. Primarily, security service companies dabbling in the cannabis industry offer services such as armored transportation, surveillance, alarms, sensors, and on-site guards. According to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in 2016 and is expected to reach USD 65 Billion by 2023.

  • This Suspect Pot Stock Is Really Getting Its Act Together
    Motley Fool8 days ago

    This Suspect Pot Stock Is Really Getting Its Act Together

    Will this top-tier marijuana grower finally get some respect from Wall Street?

  • GlobeNewswire8 days ago

    Emerald Health Therapeutics Announces Completion of Pure Sunfarms CAD$20 Million Credit Facility with Bank of Montreal and Farm Credit Canada

    OTCQX:EMHTF) today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms Corp. (“Pure Sunfarms”), has entered into a credit agreement with Bank of Montreal (“BMO”) as agent and lead lender and Farm Credit Canada (“FCC”) as lender (together with BMO, the “Lenders”) in respect of a CAD$20 million secured non-revolving term loan (the “Credit Facility”). Pure Sunfarms intends to use the funds available under the Credit Facility to finance the final costs of converting its 1.1 million square foot greenhouse for cannabis production, the vast majority of which was completed in January of this year. The funds available under the Credit Facility may also be used for general corporate purposes.

  • GlobeNewswire13 days ago

    Emerald Health Therapeutics Announces Pure Sunfarms’ Selection to Supply Ontario Cannabis Store

    OTCQX:EMHTF) today announced its cannabis joint venture, Pure Sunfarms Corp. (“Pure Sunfarms”), has through a competitive process been selected by and entered into a supply agreement with the Ontario Cannabis Retail Corporation, operating as the Ontario Cannabis Store (“OCS”), to supply the OCS with Pure Sunfarms-branded cannabis products for the non-medical market in the Province of Ontario.

  • ACCESSWIRE14 days ago

    Watch These Marijuana Stocks Enjoy A Boost From Today's Headlines

    As we see an increase in agricultural technology being used to increase the yield, and quality, of cannabis products, companies across the space will have greater access to inventory to distribute their products. Considering the fact that legal marijuana is becoming a reality in a large portion of the United States, Canada, and abroad, investors that have historically written off cannabis companies, are now flocking in droves with excitement. Nabis Holdings (INNPF) (NAB), Emerald Health Therapeutics Inc (EMHTF) (EMH.V), Green Growth Brands Inc (GGBXF), and The Supreme Cannabis Company (SPRWF) are four cannabis companies worth keeping on your radar on Thursday.

  • GlobeNewswire16 days ago

    Emerald Health Therapeutics Secures Proprietary Extraction Technology and  Extraction Capabilities in Agreement with Indena

    OTCQX:EMHTF) has entered into a license with Indena S.p.A. (“Indena”) of Milan, Italy, bearing certain exclusivity rights in Canada to use Indena’s cannabidiol (“CBD”) extraction technology, and contract manufacturing services for CBD extraction. In addition, Emerald has obtained exclusive use of Indena’s proprietary Phytosome® technology for the purpose of developing novel cannabinoid-based products with superior utility, subject to a minimum volume agreement.

  • ACCESSWIRE17 days ago

    These 4 Marijuana Stocks Could Surpass Investor Expectations

    CORAL GABLES, FL / ACCESSWIRE / February 4, 2019 / Marijuana stocks have managed to become one of the hottest topics in the news over the course of the past few years. The fact of the matter is that previously conceived notions on cannabis are being replaced by favorable public opinions supporting all possible uses of marijuana, namely as a means of treatment for patients suffering from a myriad of ailments. Global Consortium Inc (GCGX), Emerald Health Therapeutics Inc (EMHTF) (EMH.V), Trulieve Cannabis Corp (OTC PINK: TCNNF), and OrganiGram Holdings Inc (OGRMF) are four pot stocks looking to remain on high this month.

  • GlobeNewswire22 days ago

    Emerald Health Therapeutics Announces Discharge of Litigation

    OTCQX:EMHTF) announced today that its wholly-owned subsidiary, Verdélite Sciences Inc. (“Verdélite”), which operates a 75,000 square foot indoor cannabis cultivation facility in St.-Eustache, Quebec, has entered into a release, discharge and transaction agreement settling all claims made by Pivot Pharmaceuticals Inc. (“Pivot”) against Verdélite and its former shareholders, as described in Emerald’s most recent MD&A. The claims relate to a non-binding letter of intent which Verdélite and its former shareholders had previously entered into with Pivot with respect to a potential sale of Verdélite.

  • ACCESSWIRE23 days ago

    Watch These 4 Marijuana Stocks On Tuesday (1/29/19)

    One of the best indicators to look for when investing in marijuana companies is looking into the innovative efforts taken by a given company to develop and distribute the best possible product for the market. As we continue to move through this new year, the hopes are that the cannabis industry will be able to see even more gains in the future. Nabis Holdings (INNPF) (NAB), Emerald Health Therapeutics Inc (EMHTF), Curaleaf Holdings Inc (OTC PINK: CURLF), and Wayland Group Corp (MRRCF) are 4 pot stocks gaining speed on Tuesday.

  • GlobeNewswire23 days ago

    Emerald Health Therapeutics’ Licensed Endo Product Line Gains Boost with Entry into Whole Foods Market Stores Across US

    OTCQX:EMHTF)  today announced that its joint venture partner, San Diego-based Emerald Health Bioceuticals (“EHB”), has launched its award-winning Endo products in Whole Foods Markets across the United States, highlighting the unique positioning and opportunity for this product line when it is launched in Canada in 2019.  The joint venture, called Emerald Health Naturals (“EHN”), secured Canadian distribution rights for this product line that was developed to support the body’s endocannabinoid system (ECS), but which does not contain cannabis. Canadian retailers have not been announced.

  • GlobeNewswire24 days ago

    Emerald Health sees Expansion of Pure Sunfarms’ Cannabis Cultivation License to 825,000 Square Feet

    OTCQX:EMHTF) announced that its 50%-owned joint venture focused on large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, received from Health Canada its sixth amendment to its cultivation license for its 1.1 million square foot greenhouse in Delta, BC. The additional approximately 138,000 square feet brings Pure Sunfarms’ total licensed cannabis production area to approximately 825,000 square feet. The newly licensed area is expected to be fully planted and in production this week.

  • 5 Pot Stocks Wall Street Believes Will Double
    Motley Fool29 days ago

    5 Pot Stocks Wall Street Believes Will Double

    Wall Street's consensus price target for these marijuana stocks implies big gains.

  • GlobeNewswirelast month

    Emerald Health Therapeutics Closes Emerald Health Naturals Joint Venture

    OTCQX:EMHTF)  is pleased to announce that, further to its news releases dated April 17, 2018 and November 19, 2018, it has closed its 51:49 joint venture (the “Joint Venture”) with San Diego-based Emerald Health Bioceuticals (“EHB”), called Emerald Health Naturals (“EHN”).

  • ACCESSWIRElast month

    These 4 Marijuana Stocks Could Spark Activity

    CORAL GABLES, FL / ACCESSWIRE / January 8, 2019 / The beginning of the new year has already gotten off to a swift start for growth in the marijuana industry. With the new year in full swing, Leafbuyer Technologies Inc (OTC:LBUY), Emerald Health Therapeutics Inc (EMHTF), Tilray Inc (TLRY), and HEXO Corp (OTC PINK: HYYDF) (HEXO.TO) represent 4 pot stocks that are heating up on Tuesday. Leafbuyer Technologies Inc (OTC:LBUY) is a company you may not have heard of, but could greatly benefit from looking into.

  • ACCESSWIRElast month

    These 4 Marijuana Stocks Are Bringing The Heat

    CORAL GABLES, FL / ACCESSWIRE / January 7, 2019 / The cannabis industry has been notoriously successful over the course of the past several years. With the recent increase in capital and sheer amount of businesses entering the market, the nascent sector has seen unprecedented growth. As public opinion surrounding cannabis becomes increasingly more favorable, the marijuana industry may begin to present an appealing opportunity for investors looking into space.

  • Supreme Cannabis’ Target Price Changed in December
    Market Realist2 months ago

    Supreme Cannabis’ Target Price Changed in December

    Investors (MJ) have even lost money in Aphria (APHA), Emerald Health (EMHTF), and Aurora Cannabis (ACBFF), which have lost 64%, 60%, and 37% during the same period, respectively. Analysts’ consensus target price for Supreme Cannabis remained unchanged month-over-month at 3.63 Canadian dollars. The stock closed at ~1 Canadian dollars on December 19, which was at a discount of nearly 72.5%.

  • Say What? A Marijuana Stock Buying Back Its Shares
    Motley Fool2 months ago

    Say What? A Marijuana Stock Buying Back Its Shares

    This newly public pot stock just announced a $50 million share buyback.

  • GlobeNewswire2 months ago

    Emerald Health Sees License Expansion of Pure Sunfarms Cannabis Production Operation to 687,000 Square Feet, one of Largest Production Capacities in Canada

    OTCQX:EMHTF) announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, received from Health Canada the fifth amendment to its cultivation license for its 1.1 million square foot greenhouse in Delta, BC. With an added approximately 137,000 square feet (half of Quadrant 3), the total licensed cannabis production area is approximately 687,000 square feet. The newly licensed area is expected to be fully planted by the end of this week.

  • 3 Events That Defined Pot Stock Emerald Health Therapeutics' 2018
    Motley Fool3 months ago

    3 Events That Defined Pot Stock Emerald Health Therapeutics' 2018

    This has been a big year for production and product line expansion, but it doesn't necessarily make this marijuana stock a buy.